Figure 1
Figure 1. Circulating platelet-leukocyte complexes and surface-bound C3 in a patient with EHEC-associated HUS. A pediatric HUS patient had increased levels of circulating platelet-monocyte (A) and platelet-neutrophil (B) complexes during the acute phase of disease compared with levels obtained after recovery and with pediatric controls (n = 5). Levels of platelet-monocyte (A) and platelet-neutrophil (B) complexes with surface-bound C3 were elevated during the acute phase of disease and decreased at recovery to levels similar to those seen in the pediatric controls.

Circulating platelet-leukocyte complexes and surface-bound C3 in a patient with EHEC-associated HUS. A pediatric HUS patient had increased levels of circulating platelet-monocyte (A) and platelet-neutrophil (B) complexes during the acute phase of disease compared with levels obtained after recovery and with pediatric controls (n = 5). Levels of platelet-monocyte (A) and platelet-neutrophil (B) complexes with surface-bound C3 were elevated during the acute phase of disease and decreased at recovery to levels similar to those seen in the pediatric controls.

Close Modal

or Create an Account

Close Modal
Close Modal